Frank A. Nana
Brussels, BRU 1200, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.
Journal: The oncologist
Published: February 16, 2026
A detailed protocol for open and low-cost six-plex immunofluorescence (Flex-6 mIHF) with a proof-of-concept study on breast cancer tissue.
Journal: Journal of microscopy
Published: November 04, 2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 17, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Journal: Nature communications
Published: May 11, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.
Journal: Journal for immunotherapy of cancer
Published: January 03, 2025
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2024
Restin protein expression in non-small cell lung cancer.
Journal: Thoracic cancer
Published: April 03, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 19, 2022
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Journal: Frontiers in immunology
Published: July 26, 2022
A pregnant patient with ALK-positive non-small cell lung cancer treated with alectinib: A case report and review of the literature.
Journal: Oncology letters
Published: July 13, 2022
Last Updated: 09/26/2026